Soligenix (NASDAQ: SNGX) announced that SGX945 (dusquetide) has received Promising Innovative Medicine (“PIM”) designation from the U.K. Medicines and Healthcare Products Regulatory Agency for the treatment of Behçet’s Disease. The designation represents the first step toward potential inclusion in the U.K.’s Early Access to Medicines Scheme, which allows patients with life-threatening or seriously debilitating conditions […]

Recently, LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, acquired Liora Technologies, a company that is aiming to transform cancer care with innovative compact proton therapy. Specifically, Liora has created the LiGHT System, which is believed to provide many advantages over other proton therapy methods and systems that are currently available. While it […]

For patients living with rare inflammatory diseases, regulatory milestones can mark the difference between stalled research and meaningful therapeutic progress. A positive opinion from the European Medicines Agency (EMA) not only validates a drug’s scientific rationale but can also unlock development incentives that accelerate its path forward. In that context, Soligenix (NASDAQ: SNGX), a late-stage […]

HeartBeam (NASDAQ: BEAT) stands at a pivotal point in its development as a medical technology company focused on transforming how cardiac arrhythmias are detected, evaluated and monitored. Headquartered in Santa Clara, California, HeartBeam is building a platform designed starting with its FDA-cleared synthesized 12-lead ECG system to bring clinically meaningful ECG data out of traditional […]

Wearable Devices (NASDAQ: WLDS), a technology growth company specializing in artificial intelligence-powered touchless sensing wearables, announced it will implement a one-for-three reverse split of its ordinary shares and tradable warrants, effective when trading begins on a split-adjusted basis on March 11, 2026. The action is intended to increase the company’s per-share trading price to regain compliance […]

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its subsidiary HOPE Therapeutics has opened a new clinic in Palm Beach, Florida, focused on treating depression and post-traumatic stress disorder through an interventional psychiatry approach that includes ketamine and other neuroplastic drugs, transcranial magnetic stimulation (TMS), hyperbaric oxygen therapy and physician-led psychotherapy. The facility expands HOPE’s growing network […]

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising. Silvercorp Metals (TSX: SVM) (NYSE American: SVM) announced the filing of an updated Mineral Resource Estimate for the Tulkubash and Kyzyltash Chaarat Gold Projects in the Republic of Kyrgyzstan through a National Instrument 43-101 technical report titled “NI 43-101 Technical […]

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, recently acquired Liora Technologies, which is pioneering proton therapy systems for treating tumors in various types of cancers. “Liora is becoming a wholly owned subsidiary of LIXTE, and the acquisition also includes Liora’s proprietary flagship technology, the LiGHT System (Linac for Image Guided Hadron Therapy), which offers many advantages over other technologies […]

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ)  and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ), a mine development and exploration company, recently received an investment from the US federal government to advance both the exploration and development of the Upper Kobuk Mineral Projects in the northwestern […]

Artificial intelligence has triggered a global race for computing capacity, but a serious bottleneck is beginning to emerge: electricity. For companies building and operating AI infrastructure, access to reliable power is becoming as critical as access to advanced semiconductors. That shift is creating opportunities for GridAI Technologies (NASDAQ: GRDX), a technology company focused on intelligent […]

Immunotherapy has transformed cancer treatment over the past decade, yet one of oncology’s most persistent challenges remains: Many tumors simply do not respond. Even breakthrough approaches such as PD-1 and PD-L1 inhibitors and CAR-T cell therapies can fail in tumors that remain immunologically “cold” or invisible to the immune system. Researchers are increasingly focused on […]

This article has been disseminated on behalf of Ucore Rare Metals, Inc.  and may include paid advertising. Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) provided an operational and commercialization update on its “Pathway to Samarium and Gadolinium Security” project, which is focused on dedicated production planning for samarium and gadolinium rare earth oxides to support […]